ArticleCancers2024

Lenvatinib Exacerbates the Decrease in Skeletal Muscle Mass in Patients with Hepatocellular Carcinoma, Whereas Atezolizumab Plus Bevacizumab Does Not.

Kenji Imai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.